Dr. Copeland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
480 Lynnfield St
Lynn, MA 01904Phone+1 781-593-3400Fax+1 781-477-1193
Summary
- Dr. Paul Copeland is an endocrinologist in Lynn, MA and is affiliated with the Massachusetts General Hospital Weight Center. He received his medical degree from Yale School of Medicine and has been in practice 39 years. He specializes in adrenal disease, diabetes, obesity, and thyroid and is experienced in general endocrinology and osteoporosis. He has more than 50 publications and over 500 citings.
Education & Training
- Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1984
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1978 - 1981
- Yale School of MedicineClass of 1978
Certifications & Licensure
- MA State Medical License 1982 - 2025
- PA State Medical License 1979 - 1982
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
- International Society for Clinical DensitometryClinical Densitometrist
Awards, Honors, & Recognition
- Outstanding Clinical Practitioner Laureate Award The Endocrine Society, 2014
- Dr. Bennett I. Solomon Community Leadership Award Cohen Hillel Academy, 2014
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 3 citationsResults of a 2-year lifestyle intervention for type 2 diabetes: the Reach Ahead for Lifestyle and Health-Diabetes randomized controlled trial.Deborah J Wexler, Yuchiao Chang, Douglas E Levy, Bianca Porneala, Jeanna McCarthy
Obesity. 2022-10-01 - 3 citationsEDITORIAL: Eating disorders in diabetes: Discussion on issues relevant to type 1 diabetes and an overview of the Journal's special issue.Ann Goebel-Fabbri, Paul M. Copeland, Stephen Touyz, Phillipa Hay
Journal of Eating Disorders. 2019-07-18 - 4 citationsAdjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trialXiaoduo Fan, Paul M. Copeland, Shukair Nawras, Amy Harrington, Oliver Freudenreich
Psychopharmacology. 2019-02-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: